The fig summarizes the main treatment strategies for HCC. Hepatocellular carcinoma (HCC) is the most prevalent form of liver ...

as a first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma (HCC), a primary liver cancer.

Given the success of Research Topic <a href=" in Chemotherapy-Resistant Hepatocellular Carcinoma and the rapidly evolving subject area, we are pleased to announce the launch of Volume ...

Management options for hepatocellular carcinoma include locoregional therapies ... with MASH cirrhosis), liver transplantation is the primary treatment option because it has the potential to ...

Primary liver cancer is cancer that started in the liver. This section is mainly about the most common type of liver cancer, hepatocellular carcinoma (HCC). If you have cancer that started in another ...

Hepatocellular carcinoma, a type of liver cancer ... developed in this study uses variables commonly and easily tested in primary care settings. "This clinical score provides primary care ...

The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.

During a Community Case Forum event, Stacey Stein, MD, discussed data guiding the use of current regimens for the treatment ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...

LIVER cancer is the fourth most common cancer in Malaysia and also the fourth leading cause of cancer-related deaths.

The FDA has granted approval to nivolumab plus ipilimumab for use in unresectable or metastatic hepatocellular carcinoma.